Vanda Pharmaceuticals (VNDA) Stock Forecast, Price Target & Predictions
VNDA Stock Forecast
Vanda Pharmaceuticals stock forecast is as follows: an average price target of $11.00 (represents a 130.13% upside from VNDA’s last price of $4.78) and a rating consensus of 'Buy', based on 2 wall street analysts offering a 1-year stock forecast.
VNDA Price Target
VNDA Analyst Ratings
Buy
Vanda Pharmaceuticals Price Target by Analyst
Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
---|---|---|---|---|---|---|
Jul 11, 2024 | Charles Duncan | Cantor Fitzgerald | $11.00 | $5.21 | 111.13% | 130.13% |
Vanda Pharmaceuticals Price Target by Period
1M | 3M | 12M | |
---|---|---|---|
# Anlaysts | - | - | 1 |
Avg Price Target | - | - | $11.00 |
Last Closing Price | $4.78 | $4.78 | $4.78 |
Upside/Downside | -100.00% | -100.00% | 130.13% |
Analyst Ratings Upgrades/Downgrades
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
Jul 11, 2024 | Cantor Fitzgerald | Overweight | Initialise | |
Apr 26, 2022 | Zacks Investment Research | Hold | Upgrade |
Vanda Pharmaceuticals Financial Forecast
Vanda Pharmaceuticals Revenue Forecast
Quarter
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Mar 18 | Mar 17 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - | - | - | - | $38.81M | $46.06M | $62.50M | $64.48M | $65.32M | $64.39M | $60.19M | $68.02M | $70.09M | $67.90M | $62.67M | $67.65M | $60.31M | $62.21M | $58.00M | $60.93M | $59.48M | $59.06M | $47.71M | $43.59M | $37.41M |
Avg Forecast | $80.92M | $75.51M | $67.45M | $61.02M | $52.25M | $49.17M | $47.90M | $48.50M | $37.00M | $44.50M | $49.00M | $73.37M | $67.60M | $71.00M | $67.00M | $58.00M | $70.04M | $74.25M | $69.75M | $64.20M | $64.00M | $64.20M | $61.95M | $56.87M | $59.58M | $58.33M | $54.18M | $51.74M | $123.51M | $41.82M |
High Forecast | $89.76M | $83.76M | $74.81M | $63.55M | $54.30M | $49.96M | $53.13M | $53.80M | $41.04M | $49.36M | $54.35M | $88.04M | $74.98M | $71.00M | $67.00M | $58.00M | $70.04M | $74.25M | $69.75M | $64.20M | $64.00M | $64.20M | $61.95M | $56.87M | $59.58M | $58.33M | $54.18M | $51.74M | $148.21M | $50.18M |
Low Forecast | $73.91M | $68.97M | $61.60M | $58.49M | $50.20M | $48.38M | $43.75M | $44.30M | $33.79M | $40.64M | $44.75M | $58.70M | $61.74M | $71.00M | $67.00M | $58.00M | $70.04M | $74.25M | $69.75M | $64.20M | $64.00M | $64.20M | $61.95M | $56.87M | $59.58M | $58.33M | $54.18M | $51.74M | $98.81M | $33.45M |
# Analysts | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 20 | 9 | 9 | 9 | 9 | 10 | 10 | 10 | 10 | 10 | 10 | 8 | 9 | 12 | 7 | 7 | 8 | 16 | 9 |
Surprise % | - | - | - | - | - | - | - | - | - | 0.87% | 0.94% | 0.85% | 0.95% | 0.92% | 0.96% | 1.04% | 0.97% | 0.94% | 0.97% | 0.98% | 1.06% | 0.94% | 1.00% | 1.02% | 1.02% | 1.02% | 1.09% | 0.92% | 0.35% | 0.89% |
Forecast
Vanda Pharmaceuticals EBITDA Forecast
Quarter
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Mar 18 | Mar 17 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 20 | 9 | 9 | 9 | 9 | 10 | 10 | 10 | 10 | 10 | 10 | 8 | 9 | 12 | 7 | 7 | 8 | 16 | 9 |
EBITDA | - | - | - | - | - | - | - | - | - | $-6.00M | $-2.87M | $2.67M | $7.01M | $4.29M | $4.15M | $-6.97M | $9.32M | $11.43M | $13.32M | $11.14M | $10.16M | $9.12M | $11.80M | $1.96M | $6.54M | $13.00M | $12.26M | $110.00K | $3.77M | $-6.92M |
Avg Forecast | $6.16M | $5.75M | $5.14M | $4.65M | $3.98M | $3.74M | $3.65M | $-80.75M | $2.82M | $3.39M | $3.73M | $-73.41M | $6.83M | $5.18M | $4.89M | $-58.03M | $5.11M | $5.42M | $5.09M | $11.14M | $4.67M | $4.68M | $21.24M | $4.15M | $4.35M | $4.26M | $3.95M | $212.14K | $7.97M | $-7.65M |
High Forecast | $6.84M | $6.38M | $5.70M | $4.84M | $4.13M | $3.80M | $4.05M | $-64.60M | $3.13M | $3.76M | $4.14M | $-58.72M | $8.20M | $5.18M | $4.89M | $-46.42M | $5.11M | $5.42M | $5.09M | $13.37M | $4.67M | $4.68M | $25.49M | $4.15M | $4.35M | $4.26M | $3.95M | $254.57K | $9.57M | $-6.12M |
Low Forecast | $5.63M | $5.25M | $4.69M | $4.45M | $3.82M | $3.68M | $3.33M | $-96.90M | $2.57M | $3.10M | $3.41M | $-88.09M | $5.47M | $5.18M | $4.89M | $-69.63M | $5.11M | $5.42M | $5.09M | $8.91M | $4.67M | $4.68M | $16.99M | $4.15M | $4.35M | $4.26M | $3.95M | $169.71K | $6.38M | $-9.18M |
Surprise % | - | - | - | - | - | - | - | - | - | -1.77% | -0.77% | -0.04% | 1.03% | 0.83% | 0.85% | 0.12% | 1.82% | 2.11% | 2.62% | 1.00% | 2.18% | 1.95% | 0.56% | 0.47% | 1.51% | 3.06% | 3.10% | 0.52% | 0.47% | 0.90% |
Forecast
Vanda Pharmaceuticals Net Income Forecast
Quarter
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Mar 18 | Mar 17 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 20 | 9 | 9 | 9 | 9 | 10 | 10 | 10 | 10 | 10 | 10 | 8 | 9 | 12 | 7 | 7 | 8 | 16 | 9 |
Net Income | - | - | - | - | - | - | - | - | - | $137.00K | $1.52M | $3.25M | $6.86M | $3.27M | $2.57M | $-6.43M | $7.08M | $7.77M | $9.65M | $8.65M | $8.19M | $5.95M | $8.71M | $486.00K | $4.22M | $100.42M | $11.53M | $-612.00K | $3.07M | $-7.64M |
Avg Forecast | $5.24M | $4.27M | $1.17M | $-1.17M | $-5.64M | $-9.13M | $-11.07M | $-72.47M | $-5.24M | $-2.33M | $-7.57M | $-65.88M | $5.19M | $5.82M | $8.15M | $-52.08M | $4.95M | $11.06M | $8.73M | $8.65M | $8.22M | $5.55M | $15.69M | $-1.75M | $4.66M | $4.37M | $2.52M | $-1.18M | $6.49M | $-8.45M |
High Forecast | $5.99M | $4.88M | $1.33M | $-971.03K | $-5.51M | $-8.10M | $-9.82M | $-57.98M | $-4.65M | $-2.07M | $-6.72M | $-52.71M | $6.23M | $5.82M | $8.15M | $-41.67M | $4.95M | $11.06M | $8.73M | $10.38M | $8.22M | $5.55M | $18.82M | $-1.75M | $4.66M | $4.37M | $2.52M | $-944.23K | $7.79M | $-6.76M |
Low Forecast | $4.65M | $3.79M | $1.03M | $-1.26M | $-5.77M | $-10.42M | $-12.64M | $-86.97M | $-5.99M | $-2.66M | $-8.65M | $-79.06M | $4.15M | $5.82M | $8.15M | $-62.50M | $4.95M | $11.06M | $8.73M | $6.92M | $8.22M | $5.55M | $12.55M | $-1.75M | $4.66M | $4.37M | $2.52M | $-1.42M | $5.19M | $-10.14M |
Surprise % | - | - | - | - | - | - | - | - | - | -0.06% | -0.20% | -0.05% | 1.32% | 0.56% | 0.32% | 0.12% | 1.43% | 0.70% | 1.11% | 1.00% | 1.00% | 1.07% | 0.56% | -0.28% | 0.91% | 23.00% | 4.57% | 0.52% | 0.47% | 0.90% |
Forecast
Vanda Pharmaceuticals SG&A Forecast
Quarter
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Mar 18 | Mar 17 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 20 | 9 | 9 | 9 | 9 | 10 | 10 | 10 | 10 | 10 | 10 | 8 | 9 | 12 | 7 | 7 | 8 | 16 | 9 |
SG&A | - | - | - | - | - | - | - | - | - | $24.77M | $28.40M | $36.10M | $32.78M | $29.85M | $33.00M | $40.85M | $33.45M | $32.46M | $28.35M | $29.80M | $59.30M | $34.37M | $34.29M | $37.39M | $37.39M | $30.60M | $31.85M | $31.41M | $27.17M | $30.75M |
Avg Forecast | $44.05M | $41.10M | $36.71M | $33.21M | $28.44M | $26.76M | $26.07M | $26.40M | $20.14M | $24.22M | $26.67M | $39.93M | $24.53M | $38.64M | $36.47M | $31.57M | $38.12M | $40.41M | $37.96M | $29.80M | $34.83M | $34.94M | $61.71M | $30.95M | $32.43M | $31.75M | $29.49M | $28.16M | $57.54M | $33.99M |
High Forecast | $48.85M | $45.59M | $40.72M | $34.59M | $29.55M | $27.19M | $28.92M | $29.28M | $22.34M | $26.87M | $29.58M | $47.92M | $29.43M | $38.64M | $36.47M | $31.57M | $38.12M | $40.41M | $37.96M | $35.76M | $34.83M | $34.94M | $74.06M | $30.95M | $32.43M | $31.75M | $29.49M | $28.16M | $69.05M | $40.79M |
Low Forecast | $40.23M | $37.54M | $33.53M | $31.84M | $27.32M | $26.33M | $23.81M | $24.11M | $18.39M | $22.12M | $24.36M | $31.95M | $19.62M | $38.64M | $36.47M | $31.57M | $38.12M | $40.41M | $37.96M | $23.84M | $34.83M | $34.94M | $49.37M | $30.95M | $32.43M | $31.75M | $29.49M | $28.16M | $46.04M | $27.19M |
Surprise % | - | - | - | - | - | - | - | - | - | 1.02% | 1.06% | 0.90% | 1.34% | 0.77% | 0.90% | 1.29% | 0.88% | 0.80% | 0.75% | 1.00% | 1.70% | 0.98% | 0.56% | 1.21% | 1.15% | 0.96% | 1.08% | 1.12% | 0.47% | 0.90% |
Forecast
Vanda Pharmaceuticals EPS Forecast
Quarter
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Mar 18 | Mar 17 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 20 | 9 | 9 | 9 | 9 | 10 | 10 | 10 | 10 | 10 | 10 | 8 | 9 | 12 | 7 | 7 | 8 | 16 | 9 |
EPS | - | - | - | - | - | - | - | - | - | - | $0.03 | $0.06 | $0.12 | $0.06 | $0.05 | $-0.11 | $0.13 | $0.14 | $0.17 | $0.16 | $0.15 | $0.11 | $0.16 | $0.01 | $0.08 | $1.88 | $0.22 | $-0.01 | $0.07 | $-0.17 |
Avg Forecast | $0.09 | $0.07 | $0.02 | $-0.02 | $-0.10 | $-0.16 | $-0.19 | $0.05 | $-0.09 | $-0.04 | $-0.13 | $-0.10 | $0.08 | $0.10 | $0.14 | $-0.01 | $0.09 | $0.19 | $0.15 | $0.08 | $0.14 | $0.10 | $0.06 | $-0.03 | $0.08 | $0.07 | $0.04 | $0.07 | $-0.36 | $-0.21 |
High Forecast | $0.10 | $0.08 | $0.02 | $-0.02 | $-0.09 | $-0.14 | $-0.17 | $0.06 | $-0.08 | $-0.04 | $-0.12 | $-0.08 | $0.09 | $0.10 | $0.14 | $-0.01 | $0.09 | $0.19 | $0.15 | $0.08 | $0.14 | $0.10 | $0.06 | $-0.03 | $0.08 | $0.07 | $0.04 | $0.07 | $-0.29 | $-0.17 |
Low Forecast | $0.08 | $0.07 | $0.02 | $-0.02 | $-0.10 | $-0.18 | $-0.22 | $0.04 | $-0.10 | $-0.05 | $-0.15 | $-0.13 | $0.07 | $0.10 | $0.14 | $-0.01 | $0.09 | $0.19 | $0.15 | $0.08 | $0.14 | $0.10 | $0.06 | $-0.03 | $0.08 | $0.07 | $0.04 | $0.07 | $-0.43 | $-0.25 |
Surprise % | - | - | - | - | - | - | - | - | - | -0.06% | -0.20% | -0.57% | 1.50% | 0.60% | 0.36% | 11.00% | 1.53% | 0.74% | 1.13% | 2.00% | 1.06% | 1.15% | 2.90% | -0.33% | 1.00% | 25.07% | 5.08% | -0.14% | -0.19% | 0.81% |
Forecast
Vanda Pharmaceuticals Peer Comparison by Price Target
Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
---|---|---|---|---|---|
TIL | Instil Bio | $21.69 | $150.00 | 591.56% | Hold |
RLAY | Relay Therapeutics | $4.50 | $18.00 | 300.00% | Buy |
GPCR | Structure Therapeutics | $31.48 | $99.00 | 214.49% | Buy |
CGEM | Cullinan Oncology | $11.49 | $34.00 | 195.91% | Buy |
ANNX | Annexon | $4.88 | $14.00 | 186.89% | Buy |
KZR | Kezar Life Sciences | $6.52 | $17.50 | 168.40% | Buy |
LEGN | Legend Biotech | $34.68 | $89.60 | 158.36% | Buy |
NUVB | Nuvation Bio | $2.81 | $7.00 | 149.11% | Buy |
PHAT | Phathom Pharmaceuticals | $8.37 | $20.00 | 138.95% | Buy |
VNDA | Vanda Pharmaceuticals | $4.73 | $11.00 | 132.56% | Buy |
STOK | Stoke Therapeutics | $12.10 | $26.50 | 119.01% | Buy |
LQDA | Liquidia | $11.31 | $22.33 | 97.44% | Buy |
RCUS | Arcus Biosciences | $16.08 | $31.71 | 97.20% | Buy |
CYTK | Cytokinetics | $47.78 | $90.00 | 88.36% | Buy |
PCVX | Vaxcyte | $89.86 | $148.80 | 65.59% | Buy |
REPL | Replimune Group | $11.72 | $19.00 | 62.12% | Buy |
RVMD | Revolution Medicines | $45.16 | $65.67 | 45.42% | Buy |
CNTB | Connect Biopharma | $1.06 | $1.50 | 41.51% | Buy |
BMRN | BioMarin Pharmaceutical | $67.19 | $94.43 | 40.54% | Buy |
BPMC | Blueprint Medicines | $96.48 | $122.60 | 27.07% | Buy |
TECH | Bio-Techne | $75.27 | $82.33 | 9.38% | Buy |
TSVT | 2seventy bio | $3.21 | $2.00 | -37.69% | Buy |